Savran Technologies offers non-invasive diagnostics based on capture and analysis of rare cells.
Savran Technologies offers non-invasive diagnostics based on the capture and analysis of rare cells. Initial applications in oncology, immuno-oncology, and pre-natal.The company was established in 2018 and operates in Cambridge, Massachusetts, United States.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 10, 2021 | Series Unknown | $4.16M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
TBD Angels | — | Series Unknown |